Skip to main content

HubXchange

HubXChange logo

Immunotherapies Xchange - Boston - 2025

Page Banner 1

  1. Translational Immunology
    • Translational Immunology
    Use of animal models to translate the complex biology of IL-10 into humans, both as an innate anti-inflammatory and an adaptive stimulatory cytokine
    Dinesh Chandra
    Dinesh Chandra, Associate Director, Lung Cancer Initiative (LCI) - Johnson & Johnson
  2. Immune Regulation
    • Immune Regulation
    Expanding and transferring regulatory T cells to enhance immune tolerance
    Seng-Lai (Thomas) Tan
    Seng-Lai (Thomas) Tan, Chief Scientific Officer - TFC Therapeutics
  3. Immunogenicity
    • Immunogenicity
    Predicting and mitigating immunogenicity: From preclinical insights to clinical translation
    Munir Mosaheb
    Munir Mosaheb, Head of Peptide Biology - AbbVie
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Afternoon Refreshments
  5. Translational Immunology
    • Translational Immunology
    Application of multi-omics approaches to dissect immune responses and identify biomarkers associated with immunotherapy response and resistance
    Biological complexity Technical challenges Omics Data integration strategy Multi-omics strategy for ...
    Janet Wang
    Janet Wang, Vice President, Head of Translational Sciences - Arvinas
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Evening Drinks Reception
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Spotlight Presentation
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Networking Lunch
  11. Translational Immunology
    • Translational Immunology
    Leveraging computational modeling to address translational challenges in precision immunotherapy development

    Ultivue

  12. Immunogenicity
    • Immunogenicity
    Sequence optimization & computational humanization to help reduce T-cell epitope content, minimizing ADA responses
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Morning Refreshments
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    1-2-1 Meetings / Networking Break
  16. Immune Regulation
    • Immune Regulation
    Developing strategies to modulate the TME by targeting immunosuppressive cells
    Targeting Myeloid-Derived Suppressor Cells(MDSCs) Repolarizing Tumor-Associated Macrophage(TAMs) Dep ...
    Zhinan Xia
    Zhinan Xia, Founder & CSO - Abimmune Bio
  17. Clinical Development
    • Clinical Development
    Sponsor-Led Poster Presentation:
  18. Translational Immunology
    • Translational Immunology
    Sponsor-Led Poster Presentation:
  19. Immunogenicity
    • Immunogenicity
    Modulating the immune response to prevent immunogenicity/anti-drug antibodies
    Biotherapeutic modalities – What are the Inherent immunogenicity potentials and their relevance? Sho ...
    Lalit Kumar
    Lalit Kumar, Director of Clinical Bioanalytics and Translational Science - Beam Therapeutics
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Opening Address & Keynote Presentation
    • Clinical Development
    • Immune Regulation
    • Immunogenicity
    • Translational Immunology
    Registration
Search